130 related articles for article (PubMed ID: 34488527)
21. Diagnosis and treatment of extended-spectrum and AmpC beta-lactamase-producing organisms.
Yang K; Guglielmo BJ
Ann Pharmacother; 2007 Sep; 41(9):1427-35. PubMed ID: 17666573
[TBL] [Abstract][Full Text] [Related]
22. Direct Ethylenediaminetetraaceticacid-Modified β-Lactam Inactivation Method: An Improved Method to Identify Serine-Carbapenemase-, Metallo-β-Lactamase-, and Extended-Spectrum-β-Lactamase-Producing Enterobacterales Directly from Positive Blood Culture.
Bianco G; Boattini M; Iannaccone M; Zanotto E; Cavallo R; Costa C
Microb Drug Resist; 2021 Jun; 27(6):740-746. PubMed ID: 33185508
[TBL] [Abstract][Full Text] [Related]
23. Aztreonam-Avibactam Susceptibility Testing Program for Metallo-Beta-Lactamase-Producing
Bhatnagar A; Boyd S; Sabour S; Bodnar J; Nazarian E; Peinovich N; Wagner C; Craft B; Snippes Vagnone P; Simpson J; Stone VN; Therrien M; Bateman A; Lower D; Huang JY; Gumbis S; Lonsway D; Lutgring JD; Karlsson M; Brown AC
Antimicrob Agents Chemother; 2021 Jul; 65(8):e0048621. PubMed ID: 34060895
[TBL] [Abstract][Full Text] [Related]
24. Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.
Mouloudi E; Protonotariou E; Zagorianou A; Iosifidis E; Karapanagiotou A; Giasnetsova T; Tsioka A; Roilides E; Sofianou D; Gritsi-Gerogianni N
Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1250-6. PubMed ID: 20973725
[TBL] [Abstract][Full Text] [Related]
25. Assessment of Piperacillin-Tazobactam-Meropenem Synergy against Serine Carbapenemase-Producing
Lawandi A; Leite GC; Cheng MP; Lefebvre B; Longtin J; Lee TC
Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33468471
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic Options for Metallo-β-Lactamase-Producing Enterobacterales.
Tan X; Kim HS; Baugh K; Huang Y; Kadiyala N; Wences M; Singh N; Wenzler E; Bulman ZP
Infect Drug Resist; 2021; 14():125-142. PubMed ID: 33500635
[TBL] [Abstract][Full Text] [Related]
27. Clinical characteristics and outcome of critically ill patients with bacteremia caused by extended-spectrum β-lactamase-producing and non-producing Escherichia coli.
Haruki Y; Hagiya H; Haruki M; Sugiyama T
J Infect Chemother; 2018 Nov; 24(11):944-947. PubMed ID: 29803763
[TBL] [Abstract][Full Text] [Related]
28.
Lasko MJ; Abdelraouf K; Nicolau DP
Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33431414
[TBL] [Abstract][Full Text] [Related]
29. Carbapenemase producing
Karaiskos I; Galani I; Papoutsaki V; Galani L; Giamarellou H
Expert Rev Anti Infect Ther; 2022 Jan; 20(1):53-69. PubMed ID: 34033499
[TBL] [Abstract][Full Text] [Related]
30. Prospective evaluation of an easy and reliable work flow for the screening of OXA-48-producing Klebsiella pneumoniae in endemic settings.
Rodríguez-Lucas C; Rodicio MR; Rosete Y; Fernández J
J Hosp Infect; 2020 Aug; 105(4):659-662. PubMed ID: 32371082
[TBL] [Abstract][Full Text] [Related]
31. Resistance to ceftazidime/avibactam in infections and colonisations by KPC-producing Enterobacterales: a systematic review of observational clinical studies.
Di Bella S; Giacobbe DR; Maraolo AE; Viaggi V; Luzzati R; Bassetti M; Luzzaro F; Principe L
J Glob Antimicrob Resist; 2021 Jun; 25():268-281. PubMed ID: 33895414
[TBL] [Abstract][Full Text] [Related]
32. Native bone and joint infections caused by extended-spectrum β-lactamase-producing Enterobacterales: experience of a reference centre in the Greater Paris area.
Davido B; Saleh-Mghir A; Rottman M; Jaffal K; Salomon E; Bouchand F; Lawrence C; Bauer T; Herrmann JL; De Truchis P; Noussair L; Cremieux AC
Int J Antimicrob Agents; 2022 Jan; 59(1):106497. PubMed ID: 34906675
[TBL] [Abstract][Full Text] [Related]
33. In vitro activity of ceftazidime/avibactam and comparators against carbapenemase-producing Enterobacterales and Pseudomonas aeruginosa isolates collected globally between 2016 and 2018.
Kiratisin P; Kazmierczak K; Stone GG
J Glob Antimicrob Resist; 2021 Dec; 27():132-141. PubMed ID: 34478880
[TBL] [Abstract][Full Text] [Related]
34. Phenotypic detection of AmpC β-lactamases, extended-spectrum β-lactamases and metallo-β-lactamases in Enterobacteriaceae using a resazurin microtitre assay with inhibitor-based methods.
Teethaisong Y; Eumkeb G; Chumnarnsilpa S; Autarkool N; Hobson J; Nakouti I; Hobbs G; Evans K
J Med Microbiol; 2016 Oct; 65(10):1079-1087. PubMed ID: 27481506
[TBL] [Abstract][Full Text] [Related]
35. [The presence of extended spectrum beta-lactamase, KPC-type carbapenemase and plasmid-mediated AmpC beta-lactamase in E.coli and K.pneumoniae strains isolated from blood cultures].
Baykal A; Cöplü N; Simşek H; Esen B; Gür D
Mikrobiyol Bul; 2012 Apr; 46(2):159-69. PubMed ID: 22639305
[TBL] [Abstract][Full Text] [Related]
36. Early OXA-48-Producing
Gijón D; Tedim AP; Valverde A; Rodríguez I; Morosini MI; Coque TM; Manrique M; Pareja E; Tobes R; Ruiz-Garbajosa P; Cantón R
mSphere; 2020 Apr; 5(2):. PubMed ID: 32269151
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic and pharmacodynamic considerations for optimizing antimicrobial therapy used to treat bone and joint infections: an evidence-based algorithmic approach.
Gatti M; Tedeschi S; Zamparini E; Pea F; Viale P
Expert Opin Drug Metab Toxicol; 2023; 19(8):511-535. PubMed ID: 37671793
[TBL] [Abstract][Full Text] [Related]
38. Treatment options for extended-spectrum beta-lactamase (ESBL) and AmpC-producing bacteria.
D'Angelo RG; Johnson JK; Bork JT; Heil EL
Expert Opin Pharmacother; 2016; 17(7):953-67. PubMed ID: 26891857
[TBL] [Abstract][Full Text] [Related]
39. A sensitive and specific phenotypic assay for detection of metallo-β-lactamases and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented with aminophenylboronic acid, dipicolinic acid and cloxacillin.
Giske CG; Gezelius L; Samuelsen Ø; Warner M; Sundsfjord A; Woodford N
Clin Microbiol Infect; 2011 Apr; 17(4):552-6. PubMed ID: 20597925
[TBL] [Abstract][Full Text] [Related]
40. Fast-track identification of CTX-M-extended-spectrum-β-lactamase- and carbapenemase-producing Enterobacterales in bloodstream infections: implications on the likelihood of deduction of antibiotic susceptibility in emergency and internal medicine departments.
Boattini M; Bianco G; Iannaccone M; Ghibaudo D; Almeida A; Cavallo R; Costa C
Eur J Clin Microbiol Infect Dis; 2021 Jul; 40(7):1495-1501. PubMed ID: 33598829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
